Rankings
▼
Calendar
DAWN Q2 2024 Earnings — Day One Biopharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
DAWN
Day One Biopharmaceuticals, Inc.
$2B
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$8M
Gross Profit
$7M
91.4% margin
Operating Income
-$115M
-1401.5% margin
Net Income
-$4M
-53.8% margin
EPS (Diluted)
$-0.05
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$49M
Free Cash Flow
-$66M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$400M
Total Liabilities
$94M
Stockholders' Equity
$307M
Cash & Equivalents
$240M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$8M
$0
—
Gross Profit
$7M
-$92,000
+8235.9%
Operating Income
-$115M
-$49M
-133.1%
Net Income
-$4M
-$46M
+90.4%
Revenue Segments
Product
$8M
100%
← FY 2024
All Quarters
Q3 2024 →